Cerebral Palsy (CP) is a group of disorders that affect movement and muscle tone or posture. It’s caused by damage that occurs to the immature brain as it develops, most often before birth. Cerebral Palsy is the most common motor disability in childhood. Cerebral means having to do with the brain. Palsy means weakness or problems with using the muscles. CP is caused by abnormal brain development or damage to the developing brain that affects a person’s ability to control his or her muscles.
Signs and symptoms of Cerebral Palsy (CP) appear during infancy or preschool years. In general, cerebral palsy causes impaired movement associated with abnormal reflexes, floppiness or rigidity of the limbs and trunk, abnormal posture, involuntary movements, unsteady walking, or some combination of these. The symptoms of Cerebral Palsy vary from person to person. A person with severe CP might need to use special equipment to be able to walk, or might not be able to walk at all and might need lifelong care. A person with mild CP, on the other hand, might walk a little awkwardly, but might not need any special help. CP does not get worse over time, though the exact symptoms can change over a person’s lifetime.
There is no cure for Cerebral Palsy, but treatment can improve the lives of those who have the condition. Medications that can lessen muscle tightness might be used to improve functional abilities, treat pain, and manage complications related to spasticity or other cerebral palsy symptoms.
Get FREE sample copy at:
The Cerebral Palsy market report also covers emerging drugs, current treatment practices, Cerebral Palsy market share of the individual therapies, current and forecasted Cerebral Palsy Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Cerebral Palsy treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Cerebral Palsy Market Key Facts
Cerebral Palsy (CP) is the most common motor disability in childhood. Population-based studies from around the world report that the prevalence of Cerebral Palsy range from 1.5 to more than 4 per 1,000 live births or children of a defined age range. The overall birth prevalence of CP is approximately 2 per 1,000 live births.
According to some studies conducted in the United States over the past several decades, Spastic Cerebral Palsy is most common, making up 61 percent to 76.9 percent of all Cerebral Palsy cases. About 764,000 children and adults currently have Cerebral Palsy in the United States.
As per Toyokawa et al. (2016), the cerebral palsy prevalence in 5‐ to 9‐year‐olds in Japan was estimated at 2.27/1000. Peak cerebral palsy prevalence was estimated at 2.39/1000 at age 4 years.
As per the study conducted by Steven et al. (2018) studies in Australia, Europe, Canada, Sweden, and Japan have provided evidence for a declining prevalence of Cerebral Palsy over time, mostly among low-birth-weight and preterm infants.
Key Benefits of Cerebral Palsy Market Report
Cerebral Palsy market report provides an in-depth analysis of Cerebral Palsy Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
The Cerebral Palsy market report will help in developing business strategies by understanding the Cerebral Palsy Market trends & developments, key players and future market competition that will shape and drive the Cerebral Palsy market in the upcoming years.
The Cerebral Palsy market report covers Cerebral Palsy current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
The report provides a detailed assessment of the Cerebral Palsy market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Cerebral Palsy Market
The global cerebral palsy market is driving owing to the growing prevalence of cerebral palsy coupled with increasing awareness about the condition. Moreover, the growing adoption of medications for controlling the symptoms of cerebral palsy is anticipated to propel the market growth.
The Cerebral Palsy market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Cerebral Palsy market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Cerebral Palsy market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Cerebral Palsy Epidemiology
The Cerebral Palsy epidemiology section covers insights about historical and current Cerebral Palsy patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted Cerebral Palsy trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Cerebral Palsy Drugs Uptake and Key Market Players
The Cerebral Palsy Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cerebral Palsy market or expected to get launched in the market during the study period. The analysis covers Cerebral Palsy market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The clinical management of Cerebral Palsy (CP) is exceptionally challenging due to the lack of effective treatment for advanced disease. Current research focuses on elucidating the molecular events underlying the pathogenesis of brain disease, with the goal of developing new molecularly targeted therapies.
Companies across the globe are working towards the development of new treatment therapies for Cerebral Palsy (CP). Some of the key companies in Cerebral Palsy market include:
Cellular Biomedicine Group
Merck & Co.
Merz Pharmaceuticals GmbH
GW Pharmaceuticals Plc.
Cell Cure Neurosciences Ltd.
Cerebral Palsy Therapies Covered:
Robotic Ankle Assist Device (RAAD)
Umbilical Cord Mesenchymal Stem Cells
Table of Content
1. Key Insights
2. Executive Summary
3. Cerebral Palsy Competitive Intelligence Analysis
4. Cerebral Palsy Market Overview at a Glance
5. Cerebral Palsy Disease Background and Overview
6. Cerebral Palsy Patient Journey
7. Cerebral Palsy Epidemiology and Patient Population
8. Cerebral Palsy Treatment Algorithm, Current Treatment, and Medical Practices
9. Cerebral Palsy Unmet Needs
10. Key Endpoints of Cerebral Palsy Treatment
11. Cerebral Palsy Marketed Products
12. Cerebral Palsy Emerging Therapies
13. Cerebral Palsy Seven Major Market Analysis
14. Attribute Analysis
15. Cerebral Palsy Market Outlook (7 major markets)
16. Cerebral Palsy Access and Reimbursement Overview
17. KOL Views on the Cerebral Palsy Market.
18. Cerebral Palsy Market Drivers
19. Cerebral Palsy Market Barriers
21. DelveInsight Capabilities
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd 2432
City: Las Vegas
Country: United States